Dantrium: the approved drug to control malignant hyperthermia.
D003620:Dantrolene / Q000627:therapeutic use*; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000188:drug therapy*; D009730:Nursing Assessment
D003620:Dantrolene